Zika virus IgM μ-capture ELISA

供应商 ：TECAN/IBL

库存 ：大量

适应物种 ：人

In the product range of tropical diseases IBL International has now launched an ELISA for the detection of IgM antibodies based on highly sensitive and specific μ-capture technique as an aid in the serologic diagnosis of Zika virus infection, a dramatically spreading disease in the Americas and Pacific region.

Zika virus, a single-stranded RNA virus of the Flaviviridae family, is an emerging mosquito-borne virus caused by the bite of an infected Aedes mosquito. In May 2015, the public health authorities of Brazil confirmed the transmission of Zika virus in the country’s northeast. Since October 2015, other countries and territories of the Americas have reported the presence of the virus. The World Health Organization has declared the Zika virus an international public health emergency, prompted by growing concern that it could cause birth defects. As many as four million people could be infected by the end of 2016.

Symptoms are similar to those of dengue or chikungunya. Most common are skin rash, mild fever, conjunctivitis, and muscle pain. Pregnant women in general are at special risk because the infection appears to be linked to the development of unusually small heads and brain damage in newborns – called microcephaly – as well as other neurological defects. Due to these facts an early diagnosis is of utmost importance. Aside from diagnosis on clinical symptoms and epidemiological circumstances, virological and serological blood tests are important to confirm infection.

Cumulative number of countries, territories and areas by region reporting Zika virus transmission in years 2007-2016